NO20060443L - Multipartikulaert materiale - Google Patents

Multipartikulaert materiale

Info

Publication number: NO20060443L
Authority: NO; Norway
Prior art keywords: multiparticle; oxycodone; water; plasticizer; extruding
Prior art date: 2003-06-27

Application number

NO20060443A

Other languages

English (en)

Norwegian (no)

Other versions

NO333779B1 (de

Inventor

Malcom Walden

Geoff Hayes

Hassan Mohammad

Harjit Tamber

Steve Whitelock

Vincenzo Martinelli

Original Assignee

Euro Celtique Sa

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2003-06-27

Filing date

2006-01-27

Publication date

2006-01-27

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=33556051&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO20060443(L) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2003-06-27 Priority claimed from GB0315137A external-priority patent/GB0315137D0/en

2004-02-12 Priority claimed from GB0403102A external-priority patent/GB0403102D0/en

2004-06-16 Priority claimed from GB0413454A external-priority patent/GB0413454D0/en

2006-01-27 Application filed by Euro Celtique Sa filed Critical Euro Celtique Sa

2006-01-27 Publication of NO20060443L publication Critical patent/NO20060443L/no

2013-09-16 Publication of NO333779B1 publication Critical patent/NO333779B1/no

Links

239000000463 material Substances 0.000 title abstract 2
BRUQQQPBMZOVGD-XFKAJCMBSA-N Oxycodone Chemical compound O=C([C@@H]1O2)CC[C@@]3(O)[C@H]4CC5=CC=C(OC)C2=C5[C@@]13CCN4C BRUQQQPBMZOVGD-XFKAJCMBSA-N 0.000 abstract 2
229960002085 oxycodone Drugs 0.000 abstract 2
229920001577 copolymer Polymers 0.000 abstract 1
239000000314 lubricant Substances 0.000 abstract 1
239000000203 mixture Substances 0.000 abstract 1
239000003607 modifier Substances 0.000 abstract 1
230000035699 permeability Effects 0.000 abstract 1
239000004014 plasticizer Substances 0.000 abstract 1
XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1635—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
- A61K31/385—Heterocyclic compounds having sulfur as a ring hetero atom having two or more sulfur atoms in the same ring
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/485—Morphinan derivatives, e.g. morphine, codeine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1617—Organic compounds, e.g. phospholipids, fats
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A61P29/02—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID] without antiinflammatory effect

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
General Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Veterinary Medicine (AREA)
Medicinal Chemistry (AREA)
Public Health (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Epidemiology (AREA)
Organic Chemistry (AREA)
Pain & Pain Management (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Rheumatology (AREA)
Emergency Medicine (AREA)
Molecular Biology (AREA)
Neurosurgery (AREA)
Neurology (AREA)
Biophysics (AREA)
Biomedical Technology (AREA)
Medicinal Preparation (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Compositions Of Macromolecular Compounds (AREA)
Processes Of Treating Macromolecular Substances (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Agricultural Chemicals And Associated Chemicals (AREA)
Manufacturing Of Micro-Capsules (AREA)

NO20060443A 2003-06-27 2006-01-27 Multipartikulaert materiale NO20060443L (no)

Applications Claiming Priority (4)

Application Number	Priority Date	Filing Date	Title
GB0315137A GB0315137D0 (en)	2003-06-27	2003-06-27	Multiparticulates
GB0403102A GB0403102D0 (en)	2004-02-12	2004-02-12	Multiparticulates
GB0413454A GB0413454D0 (en)	2004-06-16	2004-06-16	Multiparticulates
PCT/GB2004/002705 WO2005000310A1 (en)	2003-06-27	2004-06-23	Multiparticulates

Publications (2)

Publication Number	Publication Date
NO20060443L true NO20060443L (no)	2006-01-27
NO333779B1 NO333779B1 (de)	2013-09-16

Family

ID=33556051

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO20060443A NO20060443L (no)	2003-06-27	2006-01-27	Multipartikulaert materiale

Country Status (25)

Country	Link
EP (2)	EP1889621B1 (de)
JP (2)	JP5348841B2 (de)
KR (1)	KR101116518B1 (de)
AR (1)	AR044935A1 (de)
AT (1)	ATE453394T1 (de)
AU (1)	AU2004251481B2 (de)
BR (1)	BRPI0411901B1 (de)
CA (1)	CA2530385C (de)
CY (2)	CY1109917T1 (de)
DE (1)	DE602004024888D1 (de)
DK (2)	DK1889621T3 (de)
EA (1)	EA013424B1 (de)
ES (2)	ES2490598T3 (de)
HR (2)	HRP20100127T1 (de)
IL (1)	IL172730A (de)
MX (1)	MXPA05013799A (de)
MY (1)	MY176831A (de)
NO (1)	NO20060443L (de)
NZ (1)	NZ544181A (de)
PE (1)	PE20050286A1 (de)
PL (2)	PL1889621T3 (de)
PT (2)	PT1644002E (de)
SI (2)	SI1644002T1 (de)
TW (1)	TWI357815B (de)
WO (1)	WO2005000310A1 (de)

Families Citing this family (38)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP2266564B1 (de)	1997-12-22	2013-03-13	Euro-Celtique S.A.	Peroral zu verabreichende Arzneiform enthaltend eine Kombination von einem opioid Agonisten und einem opioid Antagonisten
US6375957B1 (en)	1997-12-22	2002-04-23	Euro-Celtique, S.A.	Opioid agonist/opioid antagonist/acetaminophen combinations
JP4522652B2 (ja)	2001-05-11	2010-08-11	エンドーファーマシューティカルズ，インコーポレイティド	乱用防止制御放出オピオイド投薬形態
EP2957281A1 (de)	2001-09-21	2015-12-23	Egalet Ltd.	Polymer-freigabe-system
WO2003024430A1 (en)	2001-09-21	2003-03-27	Egalet A/S	Morphine polymer release system
LT2425824T (lt)	2002-04-05	2017-07-25	Euro-Celtique S.A.	Farmacinis preparatas, turintis oksikodono ir naloksono
US8877241B2 (en)	2003-03-26	2014-11-04	Egalet Ltd.	Morphine controlled release system
TWI357815B (en) *	2003-06-27	2012-02-11	Euro Celtique Sa	Multiparticulates
TWI350762B (en) *	2004-02-12	2011-10-21	Euro Celtique Sa	Particulates
GB0403098D0 (en) *	2004-02-12	2004-03-17	Euro Celtique Sa	Extrusion
EP1604666A1 (de)	2004-06-08	2005-12-14	Euro-Celtique S.A.	Opioide zur Behandlung der chronischen obstruktiven Lungenkrankheit
GB2418854B (en)	2004-08-31	2009-12-23	Euro Celtique Sa	Multiparticulates
EP3228308A1 (de) *	2005-01-28	2017-10-11	Euro-Celtique S.A.	Alkoholresistente darreichungsformen
EP1702558A1 (de)	2005-02-28	2006-09-20	Euro-Celtique S.A.	Verfahren und Vorrichtung zur Darmtätigkeitserfassung
US8852638B2 (en)	2005-09-30	2014-10-07	Durect Corporation	Sustained release small molecule drug formulation
AU2007205866B2 (en) *	2006-01-21	2012-11-29	Abbott Gmbh & Co. Kg	Dosage form and method for the delivery of drugs of abuse
SA07280459B1 (ar)	2006-08-25	2011-07-20	بيورديو فارما إل. بي.	أشكال جرعة صيدلانية للتناول عن طريق الفم مقاومة للعبث تشتمل على مسكن شبه أفيوني
CA2678367C (en) *	2007-03-02	2014-07-08	Farnam Companies, Inc.	Sustained release compositions using wax-like materials
JP2010531807A (ja)	2007-05-25	2010-09-30	トルマーセラピューティクス，インコーポレイテッド	リスペリドン化合物の徐放送達製剤
NZ580972A (en)	2007-06-04	2012-02-24	Egalet Ltd	Controlled release pharmaceutical compositions for prolonged effect
CN101854920B (zh)	2007-10-19	2013-05-01	大塚制药株式会社	基质型药物固体制剂
US9226907B2 (en)	2008-02-01	2016-01-05	Abbvie Inc.	Extended release hydrocodone acetaminophen and related methods and uses thereof
AU2009294308B2 (en) *	2008-09-18	2013-05-30	Purdue Pharma L.P.	Pharmaceutical dosage forms comprising poly(e-caprolactone)
WO2010089132A1 (en)	2009-02-06	2010-08-12	Egalet A/S	Immediate release composition resistant to abuse by intake of alcohol
HUE042105T2 (hu)	2009-03-10	2019-06-28	Euro Celtique Sa	Oxikodont és naloxont tartalmazó azonnali hatóanyagleadású orális gyógyászati készítmények
EP2445487A2 (de)	2009-06-24	2012-05-02	Egalet Ltd.	Retard-formulierungen
WO2011099984A1 (en) *	2010-02-11	2011-08-18	Harry Leider	Methods of normalizing measured drug concentrations and testing for non-compliance with a drug treatment regimen
US9272044B2 (en)	2010-06-08	2016-03-01	Indivior Uk Limited	Injectable flowable composition buprenorphine
GB2513060B (en)	2010-06-08	2015-01-07	Rb Pharmaceuticals Ltd	Microparticle buprenorphine suspension
BR112015000150A2 (pt)	2012-07-06	2017-06-27	Egalet Ltd	composições farmacêuticas dissuasoras de abuso de liberação controlada
EP3024461B1 (de)	2013-07-23	2020-05-13	Euro-Celtique S.A.	Kombination aus oxycodon und naloxon für die verwendung bei der behandlung von schmerzen bei patienten mit schmerzen und einer krankheit, die zur intestinaldysbiose und/oder erhöhung der gefahr bakterieller translokation führt
CA3042642A1 (en)	2013-08-12	2015-02-19	Pharmaceutical Manufacturing Research Services, Inc.	Extruded immediate release abuse deterrent pill
US10172797B2 (en)	2013-12-17	2019-01-08	Pharmaceutical Manufacturing Research Services, Inc.	Extruded extended release abuse deterrent pill
US9492444B2 (en)	2013-12-17	2016-11-15	Pharmaceutical Manufacturing Research Services, Inc.	Extruded extended release abuse deterrent pill
GB201404139D0 (en)	2014-03-10	2014-04-23	Rb Pharmaceuticals Ltd	Sustained release buprenorphine solution formulations
AU2015290098B2 (en)	2014-07-17	2018-11-01	Pharmaceutical Manufacturing Research Services, Inc.	Immediate release abuse deterrent liquid fill dosage form
US9132096B1 (en)	2014-09-12	2015-09-15	Alkermes Pharma Ireland Limited	Abuse resistant pharmaceutical compositions
US20160106737A1 (en)	2014-10-20	2016-04-21	Pharmaceutical Manufacturing Research Services, Inc.	Extended Release Abuse Deterrent Liquid Fill Dosage Form

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4861598A (en) *	1986-07-18	1989-08-29	Euroceltique, S.A.	Controlled release bases for pharmaceuticals
JPH11508224A (ja) *	1990-08-09	1999-07-21	エンドコン・インコーポレーテッド	多重ドラッグデリバリーシステム
US5266331A (en) *	1991-11-27	1993-11-30	Euroceltique, S.A.	Controlled release oxycodone compositions
US5286493A (en) *	1992-01-27	1994-02-15	Euroceltique, S.A.	Stabilized controlled release formulations having acrylic polymer coating
JP4040084B2 (ja) *	1994-02-16	2008-01-30	アボツト・ラボラトリーズ	微粒子医薬調合物の調製プロセス
US5965161A (en) *	1994-11-04	1999-10-12	Euro-Celtique, S.A.	Extruded multi-particulates
CA2219995C (en) *	1995-05-01	2004-04-13	Sam Yang Co., Ltd.	Implantable bioresorbable membrane and method for the preparation thereof
SE505146C2 (sv) *	1995-10-19	1997-06-30	Biogram Ab	Partiklar för fördröjd frisättning
WO1997045091A2 (en) *	1996-05-31	1997-12-04	Euro-Celtique, S.A.	Sustained release oxycodone formulations with no fed/fast effect
US6022554A (en) *	1997-12-15	2000-02-08	American Home Products Corporation	Polymeric microporous film coated subcutaneous implant
IT1304152B1 (it) *	1998-12-10	2001-03-08	Mediolanum Farmaceutici Srl	Composizioni comprendenti un peptide ed acido polilattico-glicolicoatte alla preparazione di impianti sottocutanei aventi un prolungato
FR2795326B1 (fr) *	1999-06-28	2001-08-31	Adir	Composition pharmaceutique solide thermoformable a liberation controlee
JP4806507B2 (ja) *	1999-10-29	2011-11-02	ユーロ−セルティークエス．エイ．	制御放出ヒドロコドン処方
EP2517710B1 (de) *	2000-02-08	2015-03-25	Euro-Celtique S.A.	Missbrauchssichere orale Opioidagonisten-Formulierungen
FR2818552B1 (fr) *	2000-12-26	2003-02-07	Servier Lab	Compositions pharmaceutique solide thermoformable pour la liberation controlee d'ivabradine
MXPA04011004A (es) *	2002-05-07	2005-01-25	Control Delivery Sys Inc	Procesos para formar un dispositivo de administracion de farmaco.
CN100594899C (zh) *	2003-01-24	2010-03-24	控制递送系统有限公司	经眼部递送碳酸酐酶抑制剂的持续释放系统和方法
TWI357815B (en) *	2003-06-27	2012-02-11	Euro Celtique Sa	Multiparticulates

2004
- 2004-06-18 TW TW093117618A patent/TWI357815B/zh not_active IP Right Cessation
- 2004-06-23 DK DK07013702.1T patent/DK1889621T3/da active
- 2004-06-23 WO PCT/GB2004/002705 patent/WO2005000310A1/en not_active Ceased
- 2004-06-23 EP EP07013702.1A patent/EP1889621B1/de not_active Expired - Lifetime
- 2004-06-23 DK DK04743056.6T patent/DK1644002T3/da active
- 2004-06-23 NZ NZ544181A patent/NZ544181A/en not_active IP Right Cessation
- 2004-06-23 PT PT04743056T patent/PT1644002E/pt unknown
- 2004-06-23 HR HR20100127T patent/HRP20100127T1/hr unknown
- 2004-06-23 SI SI200431330T patent/SI1644002T1/sl unknown
- 2004-06-23 DE DE602004024888T patent/DE602004024888D1/de not_active Expired - Lifetime
- 2004-06-23 PT PT70137021T patent/PT1889621E/pt unknown
- 2004-06-23 EA EA200600111A patent/EA013424B1/ru not_active IP Right Cessation
- 2004-06-23 EP EP04743056A patent/EP1644002B1/de not_active Expired - Lifetime
- 2004-06-23 KR KR1020057024940A patent/KR101116518B1/ko not_active Expired - Fee Related
- 2004-06-23 BR BRPI0411901-0A patent/BRPI0411901B1/pt not_active IP Right Cessation
- 2004-06-23 PL PL07013702T patent/PL1889621T3/pl unknown
- 2004-06-23 JP JP2006516468A patent/JP5348841B2/ja not_active Expired - Fee Related
- 2004-06-23 ES ES07013702.1T patent/ES2490598T3/es not_active Expired - Lifetime
- 2004-06-23 SI SI200432174T patent/SI1889621T1/sl unknown
- 2004-06-23 ES ES04743056T patent/ES2337468T3/es not_active Expired - Lifetime
- 2004-06-23 AT AT04743056T patent/ATE453394T1/de active
- 2004-06-23 PL PL04743056T patent/PL1644002T3/pl unknown
- 2004-06-23 MX MXPA05013799A patent/MXPA05013799A/es active IP Right Grant
- 2004-06-23 AU AU2004251481A patent/AU2004251481B2/en not_active Ceased
- 2004-06-23 CA CA2530385A patent/CA2530385C/en not_active Expired - Fee Related
- 2004-06-24 PE PE2004000617A patent/PE20050286A1/es not_active Application Discontinuation
- 2004-06-25 AR ARP040102264A patent/AR044935A1/es not_active Application Discontinuation
- 2004-06-25 MY MYPI20042516A patent/MY176831A/en unknown
2005
- 2005-12-21 IL IL172730A patent/IL172730A/en active IP Right Grant
2006
- 2006-01-27 NO NO20060443A patent/NO20060443L/no not_active IP Right Cessation
2010
- 2010-03-19 CY CY20101100259T patent/CY1109917T1/el unknown
2013
- 2013-05-08 JP JP2013098685A patent/JP5960089B2/ja not_active Expired - Fee Related
2014
- 2014-07-04 HR HRP20140635TT patent/HRP20140635T1/hr unknown
- 2014-07-31 CY CY20141100577T patent/CY1115415T1/el unknown

Also Published As

Publication number	Publication date
KR20060026892A (ko)	2006-03-24
CY1115415T1 (el)	2017-01-04
EP1644002A1 (de)	2006-04-12
JP5348841B2 (ja)	2013-11-20
EP1889621A1 (de)	2008-02-20
TWI357815B (en)	2012-02-11
DK1889621T3 (da)	2014-08-11
EA200600111A1 (ru)	2006-06-30
NZ544181A (en)	2008-12-24
JP2013209387A (ja)	2013-10-10
EA013424B1 (ru)	2010-04-30
MXPA05013799A (es)	2006-03-13
CA2530385A1 (en)	2005-01-06
TW200510000A (en)	2005-03-16
IL172730A (en)	2010-12-30
BRPI0411901A (pt)	2006-08-08
WO2005000310A1 (en)	2005-01-06
PE20050286A1 (es)	2005-06-13
PL1889621T3 (pl)	2014-10-31
SI1644002T1 (sl)	2010-03-31
MY176831A (en)	2020-08-24
ES2490598T3 (es)	2014-09-04
EP1889621B1 (de)	2014-05-21
EP1644002B1 (de)	2009-12-30
PL1644002T3 (pl)	2010-05-31
HRP20100127T1 (hr)	2010-04-30
NO333779B1 (de)	2013-09-16
KR101116518B1 (ko)	2012-03-13
HRP20140635T1 (hr)	2014-09-26
ES2337468T3 (es)	2010-04-26
DK1644002T3 (da)	2010-04-19
AR044935A1 (es)	2005-10-12
BRPI0411901B1 (pt)	2019-04-02
SI1889621T1 (sl)	2014-09-30
JP2007520429A (ja)	2007-07-26
JP5960089B2 (ja)	2016-08-02
PT1889621E (pt)	2014-08-27
DE602004024888D1 (de)	2010-02-11
AU2004251481A1 (en)	2005-01-06
AU2004251481B2 (en)	2010-01-28
IL172730A0 (en)	2006-04-10
ATE453394T1 (de)	2010-01-15
PT1644002E (pt)	2010-03-03
CA2530385C (en)	2013-05-28
CY1109917T1 (el)	2014-09-10

Legal Events

Date	Code	Title	Description
2020-01-27	MM1K	Lapsed by not paying the annual fees

Publication	Publication Date	Title
NO20060443L (no)	2006-01-27	Multipartikulaert materiale
NL1024013A1 (nl)	2004-03-02	Trapsgewijs (cascade) hydrodynamisch richten in microfluïde kanalen.
EP1555267A4 (de)	2010-08-18	2,3-DIHYDRO-6-NITROIMIDAZOç2,1-b]OXAZOLE
NO20070923L (no)	2007-04-19	Materiale, samt anvendelse av samme.
NL1026438A1 (nl)	2004-12-20	Nieuwe verbindingen.
BR0315742B1 (pt)	2011-03-09	conjunto de filtro.
DE60328016D1 (de)	2009-07-30	Schnelle, rekonfigurierbare sende-empfänger-architektur
BR0309292B1 (pt)	2013-05-07	mÉtodo para lixiviamento de ouro.
ITMI20030774A1 (it)	2004-10-16	Polimeri perfluorurati.
EP1549106A4 (de)	2011-01-19	Lautsprechermembran und lautsprecher, der diese verwendet
ATE440258T1 (de)	2009-09-15	Hohlspitzgeschoss
ITRM20020305A1 (it)	2003-12-01	Camptotecine con anello lattonico modificato.
ITTO20030264A1 (it)	2003-10-09	Anello.
IT1319664B1 (it)	2003-10-23	Addotti di antibatterici chinolonici con polimeri polisaccaridicinaturali.
KR100676449B9 (ko)	2023-07-18	호안 등에 사용되는 콘크리트 블록 및 그 시공 공구
ES1050454Y (es)	2002-07-16	Maquina cortadora de pizarra.
FR2853639B1 (fr)	2006-06-09	Aiguillage pneumatique.
ES1056134Y (es)	2004-06-01	Hebilla.
ITCO20020025A1 (it)	2004-05-28	Collanina salvagente.
ITMI20031370A1 (it)	2005-01-05	Immaganizzatore automatico.
TR200300829U (tr)	2004-04-21	Renkli kiremit.
ITCT20030004A1 (it)	2004-08-07	Anello multiplo.
ES1057573Y (es)	2004-12-16	Cenicero conico.
ES1053459Y (es)	2003-08-01	Dosificador termostatado.
ES1053752Y (es)	2003-08-16	Anillo.